Total Payments
$3,636
2024 Payments
$1,113
Companies
22
Transactions
63
Medicare Patients
7,644
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$3,418 (94.0%)
Education$217.30 (6.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,418 | 59 | 94.0% |
| Education | $217.30 | 4 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Baxter Healthcare | $1,094 | 15 | $0 (2024) |
| TESARO, Inc. | $451.87 | 7 | $0 (2019) |
| Pacira Pharmaceuticals Incorporated | $247.11 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $219.46 | 3 | $0 (2022) |
| Intuitive Surgical, Inc. | $207.38 | 2 | $0 (2022) |
| GlaxoSmithKline, LLC. | $163.59 | 5 | $0 (2024) |
| Clovis Oncology, Inc. | $155.43 | 9 | $0 (2019) |
| Avanos Medical | $146.24 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $134.68 | 2 | $0 (2024) |
| Genmab U.S., Inc. | $124.55 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,113 | 17 | Baxter Healthcare ($783.61) |
| 2023 | $783.53 | 9 | Baxter Healthcare ($310.43) |
| 2022 | $791.79 | 9 | Intuitive Surgical, Inc. ($207.38) |
| 2020 | $100.13 | 2 | Veran Medical Technologies, Inc. ($83.99) |
| 2019 | $380.03 | 16 | TESARO, Inc. ($174.41) |
| 2018 | $319.83 | 8 | TESARO, Inc. ($143.36) |
| 2017 | $147.23 | 2 | TESARO, Inc. ($134.10) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Baxter Healthcare | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Surgical Care | ||||||
| 08/28/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $145.64 | General |
| Category: Surgical Care | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: ONCOLOGY | ||||||
| 05/07/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $115.25 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Biological | ||||||
| 04/17/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Surgical Care | ||||||
| 04/17/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $69.13 | General |
| Category: Surgical Care | ||||||
| 04/03/2024 | Baxter Healthcare | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $148.56 | General |
| Category: Surgical Care | ||||||
| 03/29/2024 | Baxter Healthcare | FLOSEAL (Biological) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Surgical Care | ||||||
| 03/21/2024 | Baxter Healthcare | PREVELEAK (Device) | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: Surgical Care | ||||||
| 03/08/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $50.86 | General |
| Category: Surgical Care | ||||||
| 02/23/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Surgical Care | ||||||
| 02/08/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $121.81 | General |
| 01/31/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $127.35 | General |
| Category: Surgical Care | ||||||
| 09/28/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: Pain Management | ||||||
| 09/28/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $122.17 | General |
| Category: Pain Management | ||||||
| 08/31/2023 | Baxter Healthcare | TISSEEL (Device) | Food and Beverage | In-kind items and services | $99.19 | General |
| Category: Surgical Care | ||||||
| 08/08/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $104.18 | General |
| Category: ONCOLOGY | ||||||
| 07/28/2023 | Baxter Healthcare | SEPRAFILM (Device) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: Surgical Care | ||||||
| 06/28/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $121.81 | General |
| Category: ONCOLOGY | ||||||
| 06/23/2023 | Baxter Healthcare | SEPRAFILM (Device) | Food and Beverage | In-kind items and services | $42.25 | General |
| Category: Surgical Care | ||||||
| 05/30/2023 | Baxter Healthcare | TISSEEL (Device) | Food and Beverage | In-kind items and services | $105.26 | General |
| Category: Surgical Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 49 | 1,743 | 50,256 | $1.8M | $536,285 |
| 2022 | 57 | 1,870 | 46,957 | $1.3M | $378,107 |
| 2021 | 59 | 2,351 | 63,663 | $1.2M | $309,403 |
| 2020 | 53 | 1,680 | 36,526 | $1.4M | $440,967 |
Total Patients
7,644
Total Services
197,402
Medicare Billing
$1.7M
Procedure Codes
221
All Medicare Procedures & Services
221 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 13 | 5,000 | $570,000 | $216,638 | 38.0% |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | Office | 2023 | 18 | 3,565 | $325,248 | $93,563 | 28.8% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 28 | 38 | $155,175 | $39,311 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 190 | $64,980 | $23,993 | 36.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 104 | 215 | $64,500 | $19,285 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 171 | $43,263 | $14,961 | 34.6% |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | Office | 2023 | 11 | 168 | $141,624 | $14,161 | 10.0% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 16 | 14,250 | $42,750 | $12,546 | 29.3% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 18 | 18 | $38,916 | $12,173 | 31.3% |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | Office | 2023 | 19 | 2,400 | $28,800 | $11,072 | 38.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 43 | 46 | $27,616 | $7,123 | 25.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 83 | 344 | $23,736 | $7,073 | 29.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 37 | 37 | $18,130 | $6,044 | 33.3% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 21 | 3,640 | $18,200 | $4,837 | 26.6% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 28 | 38 | $17,100 | $4,767 | 27.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 64 | 519 | $13,494 | $3,901 | 28.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 50 | 373 | $13,428 | $3,795 | 28.3% |
| 86304 | Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | Office | 2023 | 44 | 190 | $13,490 | $3,752 | 27.8% |
| J3490 | Unclassified drugs | Office | 2023 | 34 | 79 | $11,762 | $3,684 | 31.3% |
| 56820 | Exam of external female genitals using an endoscope | Office | 2023 | 25 | 34 | $9,044 | $2,920 | 32.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 44 | 60 | $9,300 | $2,622 | 28.2% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 52 | 53 | $26,500 | $2,488 | 9.4% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 35 | 54 | $7,560 | $2,470 | 32.7% |
| 83735 | Magnesium level | Office | 2023 | 46 | 369 | $8,487 | $2,383 | 28.1% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 46 | 369 | $7,749 | $2,147 | 27.7% |
About Dr. Eric Thomas, MD
Dr. Eric Thomas, MD is a Obstetrics & Gynecology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2010. The National Provider Identifier (NPI) number assigned to this provider is 1881915940.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Thomas, MD has received a total of $3,636 in payments from pharmaceutical and medical device companies, with $1,113 received in 2024. These payments were reported across 63 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,418).
As a Medicare-enrolled provider, Thomas has provided services to 7,644 Medicare beneficiaries, totaling 197,402 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 221 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Oklahoma City, OK
- Active Since 06/11/2010
- Last Updated 06/11/2010
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1881915940
Products in Payments
- ZEJULA (Drug) $483.61
- PERCLOT (Device) $450.97
- TISSEEL (Biological) $298.56
- Exparel (Drug) $247.11
- TISSEEL (Device) $237.89
- Da Vinci Surgical System (Device) $207.38
- LYNPARZA (Drug) $199.90
- Rubraca (Drug) $155.43
- ON-Q* PUMP AND ACCESSORIES (Device) $146.24
- JEMPERLI (Biological) $131.85
- TIVDAK (Drug) $124.55
- LIBTAYO (Biological) $121.81
- ELAHERE (Drug) $115.25
- Avastin (Biological) $114.89
- Spin (Device) $83.99
- SEPRAFILM (Device) $72.54
- Axonics (Device) $54.36
- SARCLISA (Biological) $31.36
- FLOSEAL (Biological) $30.88
- KEYTRUDA (Biological) $30.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Oklahoma City
Kathleen Moore, Md, MD
Obstetrics & Gynecology — Payments: $872,312
Obstetrics & Gynecology $872,312
Tori O'daniel, Md, MD
Obstetrics & Gynecology — Payments: $596,012
Obstetrics & Gynecology $596,012
Lieschen Quiroz, M.d, M.D
Obstetrics & Gynecology — Payments: $41,813
Obstetrics & Gynecology $41,813
Benjamin Barenberg, M.d, M.D
Obstetrics & Gynecology — Payments: $40,741
Obstetrics & Gynecology $40,741
Beverly Vavricka, Md, MD
Obstetrics & Gynecology — Payments: $26,266
Obstetrics & Gynecology $26,266
Catherine Hildebrand, Md, MD
Obstetrics & Gynecology — Payments: $12,587
Obstetrics & Gynecology $12,587